|
|
||||||||
The Annals of Thoracic Surgery, Vol 45, 11-15, Copyright © 1988 by The Society of Thoracic Surgeons
LC Pelletier, S Montplaisir, G Pelletier, Y Castonguay, P Harvey, I Dyrda and CB Solymoss
Circulating lymphocyte subpopulations were studied in 18 consecutive
patients treated with cyclosporine-prednisone immunosuppression during the
first month following heart transplantation. Eleven patients showed no
evidence of graft rejection. There were eight episodes of acute rejection
demonstrated at endomyocardial biopsy in 7 patients. Three patients were
treated with corticosteroids, 3 were treated with rabbit antithymocyte
globulin (RATG), and 1 died before treatment (early mortality: 5.6%). Using
the monoclonal antibody technique, 150 determinations of lymphocyte
subpopulations were performed and were correlated with 72 endomyocardial
biopsy specimens. Cyclosporine immunosuppression caused a significant (p
less than 0.05) decrease in total lymphocyte count (38%) and in the number
of OKT3 (52%) and OKT4 cells (55%). During acute rejection, total
lymphocytes and OKT3, OKT4, and OKT8 cells all increased significantly, but
the T4 to T8 ratio did not change significantly. Treatment of rejection
with corticosteroids resulted in a moderate but not significant decrease in
all T-cell types, whereas RATG caused a marked but not selective decrease
in all T- cell groups. In conclusion, T cells decrease with cyclosporine
immunosuppression and with treatment of rejection and increase at onset of
rejection, but the T4 to T8 ratio has no predictive value for the diagnosis
and severity of rejection, and the sensitivity of the method does not
permit its use to assess the degree of immunosuppression with cyclosporine
following heart transplantation.
ARTICLES
Lymphocyte subpopulation monitoring in cyclosporine-treated patients following heart transplantation
Department of Surgery, Montreal Heart Institute, Ste-Justine Hospital, Que, Canada.
This article has been cited by other articles:
![]() |
P. Ferraro, M. Carrier, M. White, G. B. Pelletier, and L. C. Pelletier Antithymocyte Globulin and Methotrexate Therapy of Severe or Persistent Cardiac Allograft Rejection Ann. Thorac. Surg., August 1, 1995; 60(2): 372 - 376. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |